Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts

Breast Cancer Research

Volumn 15, Issue 4, 2013, Pages

  Zienolddiny, Shanbeh ^a   Haugen, Aage ^a   Lie, Jenny Anne S ^a   Kjuus, Helge ^a   Anmarkrud, Kristine H ^a   Kjærheim, Kristina ^b  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Breast cancer; Circadian; Clock; Night shift; SNP

Indexed keywords

ARALKYLAMINE ACETYLTRANSFERASE; PROTEIN BMAL1; RETINOID RELATED ORPHAN RECEPTOR BETA; TRANSCRIPTION FACTOR CLOCK;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NIGHT WORK; NURSE; PROTEIN FUNCTION; SHIFT WORKER; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST NEOPLASMS; EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NORWAY; OCCUPATIONAL MEDICINE; RISK;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NORWAY; NURSES; OCCUPATIONAL MEDICINE; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84879829882     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3445     Document Type: Article

References (58)

1. Downs-Holmes C, Silverman P. Breast cancer: overview & updates. Nurse Pract 2011, 36:20-27.
2. Lie JAS, Andersen A, Kjærheim K. Cancer risk among 43 000 Norwegian nurses. Scand J Work Environ Health 2007, 33:66-73. 10.5271/sjweh.1066, 17353967.
3. Poli A, Marangoni F, Visioli F. Alcohol consumption and breast cancer risk. JAMA 2012, 307:666.
4. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, Johnson N, Orr N, dos Santos Silva I, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F, Hall P, Czene K, Irwanto A, Liu J, Nevanlinna H, Aittomäki K, Blomqvist C, Meindl A, et al. Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012, 44:312-318. 10.1038/ng.1049, 3653403, 22267197, Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON).
5. Turnbull C, Seal S, Renwick A, Warren-Perry M, Hughes D, Elliott A, Pernet D, Peock S, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Ahmed M, Eccles D, Evans DG, Donnelly P, Easton DF, Stratton MR, Rahman N. Breast Cancer Susceptibility Collaboration (UK) Gene-gene interactions in breast cancer susceptibility. Hum Mol Genet 2012, 21:958-962. 10.1093/hmg/ddr525, 22072393, Breast Cancer Susceptibility Collaboration (UK).
6. Hansen J, Stevens RG. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer 2012, 48:1722-1729. 10.1016/j.ejca.2011.07.005, 21852111.
7. Hansen J, Lassen CF. Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med 2012, 69:551-556. 10.1136/oemed-2011-100240, 22645325.
8. Lie JA, Roessink J, Kjærheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes Control 2006, 17:39-44. 10.1007/s10552-005-3639-2, 16411051.
9. Lie JA, Kjuus H, Zienolddiny S, Haugen A, Stevens RG, Kjærheim K. Night work and breast cancer risk among Norwegian nurses: assessment by different exposure metrics. Am J Epidemiol 2011, 173:1272-1279. 10.1093/aje/kwr014, 21454824.
10. Menegaux F, Truong T, Anger A, Cordina-Duverger E, Lamkarkach F, Arveux P, Kerbrat P, Févotte J, Guénel P. Night work and breast cancer: a population-based case-control study in France (the CECILE study). Int J Cancer 2013, 132:924-931. 10.1002/ijc.27669, 22689255.
11. Pukkala E, Helminen M, Haldorsen T, Hammar N, Kojo K, Linnersjö A, Rafnsson V, Tulinius H, Tveten U, Auvinen A. Cancer incidence among Nordic airline cabin crew. Int J Cancer 2012, 131:2886-2897. 10.1002/ijc.27551, 22447246.
12. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology 2006, 17:108-111. 10.1097/01.ede.0000190539.03500.c1, 16357603.
13. Rushton L, Hutchings SJ, Fortunato L, Young C, Evans GS, Brown T, Bevan R, Slack R, Holmes P, Bagga S, Cherrie JW, Van Tongeren M. Occupational cancer burden in Great Britain. Br J Cancer 2012, 107(Suppl 1):S3-S7. 3384015, 22710676.
14. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 2007, 33:336-343. 10.5271/sjweh.1150, 17973059.
15. Pesch B, Harth V, Rabstein S, Baisch C, Schiffermann M, Pallapies D, Bonberg N, Heinze E, Spickenheuer A, Justenhoven C, Brauch H, Hamann U, Ko Y, Straif K, Brüning T. Night work and breast cancer: results from the German GENICA study. Scand J Work Environ Health 2010, 36:134-141. 10.5271/sjweh.2890, 20039012.
16. O'Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, Gammon MD, Leske MC. Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol 2006, 164:358-366. 10.1093/aje/kwj211, 16777931.
17. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Painting, firefighting, and shiftwork. IARC Monogr Eval Carcinog Risks Hum 2010, 98:9-764. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
18. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L, Cogliano V. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007, 8:1065-1066. 10.1016/S1470-2045(07)70373-X, 19271347.
19. Stevens RG. Testing the light-at-night (LAN) theory for breast cancer causation. Chronobiol Int 2011, 28:653-656. 10.3109/07420528.2011.606945, 21929297.
20. Blask DE, Hill SM, Dauchy RT, Xiang S, Yuan L, Duplessis T, Mao L, Dauchy E, Sauer LA. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res 2011, 51:259-269. 10.1111/j.1600-079X.2011.00888.x, 3162043, 21605163.
21. Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 2005, 16:254-258. 10.1097/01.ede.0000152525.21924.54, 15703542.
22. Davis S, Mirick DK, Chen C, Stanczyk FZ. Night shift work and hormone levels in women. Cancer Epidemiol Biomarkers Prev 2012, 21:609-618. 10.1158/1055-9965.EPI-11-1128, 22315366.
23. Dumont M, Lanctôt V, Cadieux-Viau R, Paquet J. Melatonin production and light exposure of rotating night workers. Chronobiol Int 2012, 29:203-210. 10.3109/07420528.2011.647177, 22324558.
24. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol 2012, 351:152-166. 10.1016/j.mce.2012.01.004, 3288509, 22245784.
25. Hill SM, Spriggs LL, Simon MA, Muraoka H, Blask DE. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 1992, 64:249-256. 10.1016/0304-3835(92)90050-6, 1638517.
26. Hill SM, Collins A, Kiefer TL. The modulation of oestrogen receptor-α activity by melatonin in MCF-7 human breast cancer cells. Eur J Cancer 2000, 36(Suppl 4):117-118.
27. Sánchez-Hidalgo M, Lee M, de la Lastra CA, Guerrero JM, Packham G. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines. J Pineal Res 2012, 53:366-373. 10.1111/j.1600-079X.2012.01006.x, 22582944.
28. Tamura H, Takasaki A, Taketani T, Tanabe M, Kizuka F, Lee L, Tamura I, Maekawa R, Asada H, Yamagata Y, Sugino N. Melatonin as a free radical scavenger in the ovarian follicle. Endocr J 2013, 60:1-13. 10.1507/endocrj.EJ12-0263, 23171705.
29. Morceli G, Honorio-França AC, Fagundes DL, Calderon IM, França EL. Antioxidant effect of melatonin on the functional activity of colostral phagocytes in diabetic women. PLoS One 2013, 8:e56915. 10.1371/journal.pone.0056915, 3577679, 23437270.
30. Haus EL, Smolensky MH. Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev 2013, 17:273-284. 10.1016/j.smrv.2012.08.003, 23137527.
31. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 2006, 66:5521-5525. 10.1158/0008-5472.CAN-05-4652, 16707482.
32. Girschik J, Heyworth J, Fritschi L. Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study. Am J Epidemiol 2013, 177:316-327. 10.1093/aje/kws422, 23324334.
33. Griffett K, Burris TP. The mammalian clock and chronopharmacology. Bioorg Med Chem Lett 2013, 23:1929-1934. 10.1016/j.bmcl.2013.02.015, 23481644.
34. Panda S, Sato TK, Castrucci AM, Rollag MD, DeGrip WJ, Hogenesch JB, Provencio I, Kay SA. Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science 2002, 298:2213-2216. 10.1126/science.1076848, 12481141.
35. Zmrzljak UP, Rozman D. Circadian regulation of the hepatic endobiotic and xenobiotic detoxification pathways: the time matters. Chem Res Toxicol 2012, 25:811-824. 10.1021/tx200538r, 22303888.
36. Gery S, Koeffler HP. The role of circadian regulation in cancer. Cold Spring Harb Symp Quant Biol 2007, 72:459-464. 10.1101/sqb.2007.72.004, 18419305.
37. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-Guillaume G, Halberg F. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 2006, 97:589-596. 10.1111/j.1349-7006.2006.00225.x, 2662332, 16827798.
38. Gu X, Xing L, Shi G, Liu Z, Wang X, Qu Z, Wu X, Dong Z, Gao X, Liu G, Yang L, Xu Y. The circadian mutation PER2S662G is linked to cell cycle progression and tumorigenesis. Cell Death Differ 2012, 19:397-405. 10.1038/cdd.2011.103, 3278723, 21818120.
39. Dai H, Zhang L, Cao M, Song F, Zheng H, Zhu X, Wei Q, Zhang W, Chen K. The role of polymorphisms in circadian pathway genes in breast tumorigenesis. Breast Cancer Res Treat 2011, 127:531-540. 10.1007/s10549-010-1231-2, 20978934.
40. Larsen IK, Småstuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Møller B. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009, 45:1218-1231. 10.1016/j.ejca.2008.10.037, 19091545.
41. Wakefield J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet 2007, 81:208-227. 10.1086/519024, 1950810, 17668372.
42. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004, 96:434-442. 10.1093/jnci/djh075, 15026468.
43. Wacholder S, Struewing JP, Hartge P, Greene MH, Tucker MA. Breast cancer risks for BRCA1/2 carriers. Science 2004, 306:2187-2191.
44. Hung RJ, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Chabrier A, Borel S, Hall J, Boffetta P. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005, 97:567-576. 10.1093/jnci/dji101, 15840879.
45. Kovanen L, Saarikoski ST, Haukka J, Pirkola S, Aromaa A, Lönnqvist J, Partonen T. Circadian clock gene polymorphisms in alcohol use disorders and alcohol consumption. Alcohol Alcohol 2010, 45:303-311. 10.1093/alcalc/agq035, 20554694.
46. Kovanen L, Saarikoski ST, Aromaa A, Lönnqvist J, Partonen T. ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality. PLoS One 2010, 5:e10007. 10.1371/journal.pone.0010007, 2848852, 20368993.
47. Zhu Y, Stevens RG, Hoffman AE, Fitzgerald LM, Kwon EM, Ostrander EA, Davis S, Zheng T, Stanford JL. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res 2009, 69:9315-9322. 10.1158/0008-5472.CAN-09-0648, 2955869, 19934327.
48. Hoffman AE, Zheng T, Ba Y, Zhu Y. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res 2008, 6:1461-1468. 10.1158/1541-7786.MCR-07-2094, 2572675, 18819933.
49. Hoffman AE, Zheng T, Ba Y, Stevens RG, Yi CH, Leaderer D, Zhu Y. Phenotypic effects of the circadian gene cryptochrome 2 on cancer-related pathways. BMC Cancer 2010, 10:110. 10.1186/1471-2407-10-110, 2860360, 20334671.
50. Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y, Holford TR, Hansen J, Paulson J, Zhu Y. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res 2010, 70:1459-1468. 10.1158/0008-5472.CAN-09-3798, 3188957, 20124474.
51. Zhou F, He X, Liu H, Zhu Y, Jin T, Chen C, Qu F, Li Y, Bao G, Chen Z, Xing J. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer. Cancer 2012, 118:937-946. 10.1002/cncr.26348, 21773969.
52. Reszka E, Peplonska B, Wieczorek E, Sobala W, Bukowska A, Gromadzinska J, Lie JA, Kjuus H, Wasowicz W. Circadian gene expression in peripheral blood leukocytes of rotating night shift nurses. Scand J Work Environ Health 2013, 39:187-194. 10.5271/sjweh.3303, 22552736.
53. Reszka E, Peplonska B, Wieczorek E, Sobala W, Bukowska A, Gromadzinska J, Lie JA, Kjuus H, Wasowicz W. Rotating night shift work and polymorphism of genes important for the regulation of circadian rhythm. Scand J Work Environ Health 2013, 39:178-186. 10.5271/sjweh.3299, 22517501.
54. Monsees GM, Kraft P, Hankinson SE, Hunter DJ, Schernhammer ES. Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer 2012, 131:2547-2552. 10.1002/ijc.27564, 22473669.
55. McGrath CL, Glatt SJ, Sklar P, Le-Niculescu H, Kuczenski R, Doyle AE, Biederman J, Mick E, Faraone SV, Niculescu AB, Tsuang MT. Evidence for genetic association of RORB with bipolar disorder. BMC Psychiatry 2009, 9:70. 10.1186/1471-244X-9-70, 2780413, 19909500.
56. Akashi M, Takumi T. The orphan nuclear receptor RORα regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 2005, 12:441-448. 10.1038/nsmb925, 15821743.
57. Hoffman AE, Zheng T, Yi CH, Stevens RG, Ba Y, Zhang Y, Leaderer D, Holford T, Hansen J, Zhu Y. The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev Res (Phila) 2010, 3:539-548.
58. Boden MJ, Kennaway DJ. Circadian rhythms and reproduction. Reproduction 2006, 132:379-392. 10.1530/rep.1.00614, 16940279.